PODD vs. DXCM

In the year-to-date period, PODD achieves a 18.24% return, which is significantly higher than DXCM's -38.90% return. Both investments have delivered pretty close results over the past 10 years, with PODD having a 18.60% annualized return and DXCM not far behind at 18.35%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Insulet Corporation (PODD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PODD Sharpe Ratio is 0.52, which is higher than the DXCM Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of PODD and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither PODD nor DXCM has paid dividends to shareholders.

The maximum PODD drawdown since its inception was -90.28%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for PODD and DXCM. For additional features, visit the drawdowns tool.

The current volatility for Insulet Corporation (PODD) is 6.01%, while DexCom, Inc. (DXCM) has a volatility of 9.99%. This indicates that PODD experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Insulet Corporation and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.